About Mednext Pharma Private Limited
Data last updated:
Mednext Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 February 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2009PTC190076. Its GSTIN is 08AAFCM9447H1Z2 (Rajasthan). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹50.5 Lakh. It is led by directors Anil Kumar Vyas and Neelam Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 901 Sai Anant Smit Chs Pl – 12 Sect – 30 Vashi, Navi Mumbai, Maharashtra, India – 410209.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.56 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹49.5 Lakh (net margin 19.4%) and EBITDA of ₹59.44 Lakh (EBITDA margin 23.2%). Revenue has declined at a compounded annual rate (CAGR) of 56% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹19.82 Cr and satisfied charges of ₹1.1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mednextpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressFlat No. 901 Sai Anant Smit Chs Pl – 12 Sect – 30 Vashi, Navi Mumbai, Maharashtra, India – 410209
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mednext Pharma Private Limited
The main business activity of Mednext Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mednext Pharma Private Limited FY 2025 filings available
Mednext Pharma Private Limited reported revenue of ₹2.56 Cr (up 281% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Mednext Pharma Private Limited
Revenue rose 281% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 20%. EBITDA rose 967% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mednext Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹59.44 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹49.5 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mednext Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 19.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mednext Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mednext Pharma Private Limited
Mednext Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmaceutical Business Group(India) Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Ahen Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | 14 | Ahmedabad, Gujarat, India |
| Troikaa Pharmachem Private Limited | •••• | •••• | •••• | •••• | - | Ahmadabad City, Gujarat, India |
| Alican Pharmaceutical Private Limited | •••• | •••• | •••• | •••• | - | Daskroi, Gujarat, India |
| Favisor Life Sciences Private Limited | •••• | •••• | •••• | •••• | - | Bangalore North, Karnataka, India |
| Mednext Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Navi Mumbai, Maharashtra, India |
| Mediconectar Pharmacy Private Limited | •••• | •••• | •••• | •••• | - | Delhi, India |
| Soulchem Life Science Private Limited | •••• | •••• | •••• | •••• | - | Jaipur, Rajasthan, India |
| Frismed Life Science Private Limited | •••• | •••• | •••• | •••• | - | Sector -45, Haryana, India |
| Prospero Healthcare Private Limited | •••• | •••• | •••• | •••• | - | Kalol, Gujarat, India |
| Gautam Medilife Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Mednext Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Mednext Pharma Private Limited
Mednext Pharma Private Limited is audited by V C VYAS & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V C VYAS & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mednext Pharma Private Limited
Mednext Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Vyas Also directs: Ceza Formulations Private Limited, Alice Pharma Private Limited, Mednext Biotech Limited and 1 more | Director | 03 Feb 2009 | 17 Years 8 Months | Current |
| Neelam Vyas Also directs: Alice Pharma Private Limited, Mednext Biotech Limited, Tirtham Hospitality Private Limited and 1 more | Director | 04 Mar 2017 | 9 Years 7 Months | Current |
Ownership and Shareholding of Mednext Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mednext Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2022 | Others | ₹16.59 Cr | Open |
| 19 Feb 2016 | Axis Bank Limited | ₹2.23 Cr | Open |
| 16 Jan 2015 | Indusland Bank Limited | ₹1 Cr | Open |
| 21 Oct 2013 | Canara Bank | ₹1.1 Cr | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Mednext Pharma Private Limited
Employment history and EPFO contributions of people linked to Mednext Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mednext Pharma Private Limited
Mednext Pharma Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Neelam Vyas was appointed as Director on 04 Mar 2017.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Mednext Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mednext Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mednext Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mednext Pharma Private Limited
Mednext Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAFCM9447H1Z2 | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mednext Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mednext Pharma Private Limited
Mednext Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 February 2009 (17+ years old) and is registered under CIN U24110MH2009PTC190076.
Mednext Pharma reported revenue of ₹2.56 Cr for FY 2024 (up 281% YoY).
Mednext Pharma has 2 current directors:
- Anil Kumar Vyas - Director
- Neelam Vyas - Director
Mednext Pharma reported a net profit of ₹49.5 Lakh (net margin 19.4%) and EBITDA of ₹59.44 Lakh (EBITDA margin 23.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mednext Pharma is 56% over three years and -20% over five years. In the latest year (FY 2024) revenue rose 281%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mednext Pharma is 08AAFCM9447H1Z2, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Mednext Pharma is U24110MH2009PTC190076. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mednext Pharma was incorporated on 03 February 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mednext Pharma by revenue are Pharmaceutical Business Group(India) Limited, Ahen Pharmaceuticals Private Limited, Troikaa Pharmachem Private Limited, Alican Pharmaceutical Private Limited, Favisor Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Neelam Vyas was appointed as Director on 04 Mar 2017. Alex Charles Fernandes ceased to be Director on 16 Apr 2012. Harsh Bulla ceased to be Additional Director on 30 Sep 2010. Mednext Pharma has 4 board changes on record in total.
Mednext Pharma can be reached through the website mednextpharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.